Catalyst Wire Dossier Catalyst Wire Dossier

m-FOLFOXIRI

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for m-FOLFOXIRI, covering 2019-03-13 to 2019-03-13. Get the full timeline:

Most recent: Clinical Trial Update: The Efficacy of Bevacizumab Combined With m-FOLFOXIRI in Borderline Resectable Colorectal Liver Metastases [Phase 2]

See pricing